SINSIN PHARMACEUTICAL Co., LTD. — Investor Relations & Filings
Filings indexed
175
across all filing types
Latest filing
2024-12-12
Notice of Dividend Amou…
Country
KR
South Korea
Listing
KO
002800
Sinsin Pharmaceutical Co., Ltd. is a pharmaceutical company that specializes in the development, manufacturing, and marketing of over-the-counter (OTC) medicines for external use. The company's core product portfolio centers on topical anti-inflammatory and analgesic drugs, including its widely recognized brand of pain relief patches, "SINSIN PAS," alongside various sprays and lotions. The company also produces a diverse range of consumer healthcare items such as mosquito repellents, wound care products like surgical plasters and healing bands, anti-mycotic treatments, and other dermatological preparations for both domestic and overseas markets.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 주주명부폐쇄기간또는기준일설정 | 2024-12-12 | Korean | |
| 분기보고서 (2024.09) | 2024-11-14 | Korean | |
| 반기보고서 (2024.06) | 2024-08-14 | Korean | |
| 투자판단관련주요경영사항(임상시험계획승인신청등결정) (과민성 방광 환자를 대상으로 UIP620의 유효성 및 안전성을 평가하기 위한 무작위배정, 이중눈가림, 다기관, 제3상 임상시험계획IND 승인) | 2024-07-15 | Korean | |
| 투자판단관련주요경영사항(임상시험계획승인신청등결정) (불면증 환자의 단기치료제 SS262의 임상 1상 임상시험계획IND 승인) | 2024-05-28 | Korean | |
| 분기보고서 (2024.03) | 2024-05-14 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 8007080 | 주주명부폐쇄기간또는기준일설정 | 2024-12-12 | Korean | ||
| 8017961 | 분기보고서 (2024.09) | 2024-11-14 | Korean | ||
| 8095951 | 반기보고서 (2024.06) | 2024-08-14 | Korean | ||
| 8109150 | 투자판단관련주요경영사항(임상시험계획승인신청등결정) (과민성 방광 환자를 대상으로 UIP620의 유효성 및 안전성을 평가하기 위한 무작위배정, 이중눈가림, 다기관, 제3상 임상시험계획IND 승인) | 2024-07-15 | Korean | ||
| 8133256 | 투자판단관련주요경영사항(임상시험계획승인신청등결정) (불면증 환자의 단기치료제 SS262의 임상 1상 임상시험계획IND 승인) | 2024-05-28 | Korean | ||
| 8140359 | 분기보고서 (2024.03) | 2024-05-14 | Korean | ||
| 8147204 | 투자판단관련주요경영사항(임상시험계획승인신청) (과민성 방광 환자를 대상으로 UIP620의 유효성 및 안전성을 평가하기 위한 무작위배정, 이중눈가림, 다기관, 제3상 임상시험) | 2024-04-17 | Korean | ||
| 8147817 | 주요사항보고서(영업정지) | 2024-04-15 | Korean | ||
| 8147815 | 주권매매거래정지 (중요한 영업정지) | 2024-04-15 | Korean | ||
| 8154751 | 주식등의대량보유상황보고서(일반) | 2024-03-28 | Korean | ||
| 8154547 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2024-03-28 | Korean | ||
| 8163523 | 정기주주총회결과 | 2024-03-21 | Korean | ||
| 8162936 | 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2024-03-21 | Korean | ||
| 8188292 | 감사보고서제출 | 2024-03-13 | Korean | ||
| 8187541 | 사업보고서 (2023.12) | 2024-03-13 | Korean | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
SINSIN PHARMACEUTICAL Co., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17098/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17098 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17098 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17098 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17098}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SINSIN PHARMACEUTICAL Co., LTD. (id: 17098)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.